APP and Alzheimer disease: Hence, studies have attempted to use liposomal microRNA-195 as a possible therapy for AD: intravenous nanoliposomes encapsulating [59,60] (PEI)/miR-195 complex (DPMT@PEI/miR-195) can alleviate cognitive decline in APP/PS1 mice—an animal model of AD) [141].